ReviewGenes & diseases2023
A new emerging target in cancer immunotherapy: Galectin-9 (LGALS9).
Yan Lv et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
123 papers cite itlatest 60 shown
this papercites it
ReviewGenes & diseases2023
Yan Lv et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.